Barclays PLC Adagene Inc. Call Options Transaction History
Barclays PLC
- $327 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ADAG
# of Institutions
14Shares Held
9.89MCall Options Held
0Put Options Held
0-
Wu Xi App Tec Co., Ltd. Shanghai, F43.98MShares$12.1 Million52.26% of portfolio
-
Fil LTD Hamilton, D03.83MShares$11.7 Million0.01% of portfolio
-
Sc China Holding LTD N/A, K31.34MShares$4.1 Million0.15% of portfolio
-
General Atlantic LLC New York, NY264KShares$805,2000.03% of portfolio
-
Exome Asset Management LLC New York, NY151KShares$460,1710.4% of portfolio
About Adagene Inc.
- Ticker ADAG
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,423,200
- Market Cap $132M
- Description
- Adagene Inc., a clinical stage biopharmaceutical company, engages in the research, development, and production of monoclonal antibody drugs for cancers. The company's product candidates include ADG106, a human ligand-blocking agonistic anti-CD137 monoclonal antibodies (mAbs) that is in Phase 1b/2 clinical trials for the treatment advanced solid ...